News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
302,755 Results
Type
Article (8585)
Company Profile (113)
Press Release (294057)
Section
Business (105974)
Career Advice (679)
Deals (18431)
Drug Delivery (20)
Drug Development (32016)
Employer Resources (44)
FDA (4767)
Job Trends (5874)
News (161185)
Policy (10236)
Tag
Academia (546)
Alliances (22558)
Alzheimer's disease (406)
Approvals (4751)
Artificial intelligence (35)
Bankruptcy (124)
Best Places to Work (4426)
Biotechnology (106)
Breast cancer (49)
Cancer (360)
Career advice (595)
Cell therapy (106)
Clinical research (25597)
Collaboration (146)
Compensation (77)
COVID-19 (646)
C-suite (51)
Data (392)
Diabetes (35)
Diagnostics (2427)
Earnings (44843)
Employer resources (45)
Events (52943)
Executive appointments (167)
FDA (4932)
Funding (131)
Gene therapy (52)
GLP-1 (160)
Government (688)
Healthcare (5962)
Infectious disease (667)
Inflammatory bowel disease (49)
Interviews (78)
IPO (9209)
Job creations (1605)
Job search strategy (547)
Layoffs (120)
Legal (2793)
Lung cancer (30)
Manufacturing (67)
Medical device (4103)
Medtech (4104)
Mergers & acquisitions (9277)
Metabolic disorders (110)
Neuroscience (494)
NextGen Class of 2024 (2268)
Non-profit (954)
Northern California (679)
Obesity (62)
Opinion (68)
Parkinson's disease (30)
People (32791)
Phase I (8653)
Phase II (11560)
Phase III (7771)
Pipeline (135)
Postmarket research (753)
Preclinical (3609)
Press Release (72)
Radiopharmaceuticals (136)
Rare diseases (64)
Real estate (2893)
Regulatory (7076)
Research institute (535)
Resumes & cover letters (91)
Southern California (567)
Startups (1694)
United States (5820)
Vaccines (76)
Weight loss (31)
Date
Today (137)
Last 7 days (450)
Last 30 days (1480)
Last 365 days (17516)
2024 (14963)
2023 (19744)
2022 (26144)
2021 (27424)
2020 (24340)
2019 (17743)
2018 (13705)
2017 (14094)
2016 (13134)
2015 (16390)
2014 (12902)
2013 (10493)
2012 (11398)
2011 (12104)
2010 (11671)
Location
Africa (289)
Arizona (60)
Asia (16940)
Australia (3070)
California (1461)
Canada (621)
China (61)
Colorado (42)
Connecticut (59)
Europe (36528)
Florida (164)
Illinois (136)
Indiana (79)
Kansas (33)
Maine (33)
Maryland (198)
Massachusetts (1232)
Michigan (102)
Minnesota (129)
New Jersey (396)
New York (422)
North Carolina (355)
Northern California (679)
Ohio (55)
Pennsylvania (350)
South America (438)
Southern California (567)
Texas (161)
Utah (32)
Washington State (237)
302,755 Results for "golden biotechnology corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Allergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Accelerate Aesthetics Start-Ups
University Lab Partners (ULP) is thrilled to announce the return of the Golden Ticket pitch competition for aesthetic startups, proudly sponsored by Allergan Aesthetics, an AbbVie Company.
April 12, 2024
·
2 min read
ASCO GI 2024: Golden Biotech’s Antroquinonol Shows Significantly Prolonged Survival in Untreated Metastatic Pancreatic Cancer Patients
Golden Biotechnology Corp. had unveiled the findings of its Phase II clinical trial investigating Antroquinonol in combination with the standard of care: nab-paclitaxel + gemcitabine, as first-line treatment for metastatic pancreatic cancer.
January 18, 2024
·
5 min read
BioForest
Golden Helix Receives New NIH SBIR Grant
Golden Helix, Inc. announced that it was awarded the NIH SBIR Grant 1R43HG013456-01 “Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options.”.
September 26, 2023
·
1 min read
Pharm Country
Golden State Medical Supply (GSMS) selects Finarb Analytics Consulting as its trusted Partner for AI enabled Demand Forecasting for their generics business
Golden State Medical Supply, a leading provider of generic pharmaceuticals to the US Federal Government and Finarb Analytics Consulting, a consult-to-operate data and AI solutions provider, have announced a strategic partnership to develop an AI enabled demand forecasting model to accurately estimate demand across all client facilities of GSMS.
February 6, 2024
·
2 min read
Press Releases
Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
October 31, 2024
·
17 min read
Press Releases
PairX Bio Clinches Coveted Amgen Golden Ticket Award, as NSG BioLabs Deepens Efforts with Partners CapitaLand and Amgen to Boost Singapore’s Biotech Ecosystem with Fourth Site and Extended Awards Programme
July 18, 2024
·
9 min read
Press Releases
Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones
November 4, 2024
·
8 min read
Layoffs
Sana Biotechnology Will Lay Off Employees as It Shifts Pipeline
About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 diabetes program and looks to extend its cash runway.
November 5, 2024
·
1 min read
·
Angela Gabriel
Business
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
19 min read
Business
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced results for the first quarter ended 2024 and provided a corporate update.
May 29, 2024
·
18 min read
1 of 30,276
Next